Glycopyrrolate and Electrocardiogram st segment elevation - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment elevation is reported as a side effect among people who take Glycopyrrolate (glycopyrrolate), especially for people who are male, 50-59 old, also take Propofol, and have Arrhythmias.

The phase IV clinical study analyzes which people have Electrocardiogram st segment elevation when taking Glycopyrrolate. It is created by eHealthMe based on reports of 5,510 people who have side effects when taking Glycopyrrolate from the FDA, and is updated regularly.

What is Glycopyrrolate?

Glycopyrrolate has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 5,599 Glycopyrrolate users. Check the latest studies of Glycopyrrolate.

What is Electrocardiogram st segment elevation?

Electrocardiogram st segment elevation is found to be associated with 397 drugs and 813 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment elevation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

5,510 people reported to have side effects when taking Glycopyrrolate.
Among them, 17 people (0.31%) have Electrocardiogram st segment elevation.

Could Glycopyrrolate cause Electrocardiogram st segment elevation?

Among these 17 people:

What is the gender of people who have Electrocardiogram st segment elevation when taking Glycopyrrolate? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Electrocardiogram st segment elevation when taking Glycopyrrolate? *

What are other drugs people take besides Glycopyrrolate? *

What are other side effects people have besides Electrocardiogram st segment elevation? *

Nausea (feeling of having an urge to vomit): 11 people, 64.71%
Hypotension (abnormally low blood pressure): 11 people, 64.71%
Nausea And Vomiting: 11 people, 64.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 47.06%
Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries): 7 people, 41.18%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 6 people, 35.29%
Chest Pain: 6 people, 35.29%
Acute Kidney Failure: 5 people, 29.41%
Blood Pressure Systolic Increased: 5 people, 29.41%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 29.41%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 4 people, 23.53%
Anaesthesia: 3 people, 17.65%
Post Procedural Complication: 1 person, 5.88%
Neuromuscular Blockade Reversal: 1 person, 5.88%
Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
General Anaesthesia: 1 person, 5.88%
Bone Pain: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Glycopyrrolate and have Electrocardiogram st segment elevation?

- Check whether Electrocardiogram st segment elevation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glycopyrrolate:

Glycopyrrolate (5,599 reports)

Electrocardiogram st segment elevation treatments and more:

Electrocardiogram st segment elevation (4,750 reports)

How severe was Electrocardiogram st segment elevation and when was it recovered:

Electrocardiogram st segment elevation in Glycopyrrolate

Expand to all the drugs that have ingredients of glycopyrrolate:

Electrocardiogram st segment elevation and drugs with ingredients of glycopyrrolate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glycopyrrolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st segment elevation:

Electrocardiogram st segment elevation (397 drugs)

Browse all the conditions that are associated with Electrocardiogram st segment elevation:

Electrocardiogram st segment elevation (813 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Glycopyrrolate) and Glycopyrrolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.